137 related articles for article (PubMed ID: 38656214)
1. Perspectives on Injectable HIV Pre-Exposure Prophylaxis: A Qualitative Study of Health Care Providers in the United States.
Bleasdale J; McCole M; Cole K; Hequembourg A; Morse GD; Przybyla SM
AIDS Patient Care STDS; 2024 Apr; 38(4):177-184. PubMed ID: 38656214
[TBL] [Abstract][Full Text] [Related]
2. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
[TBL] [Abstract][Full Text] [Related]
3. Health Care Provider Perspectives on Pre-exposure Prophylaxis: A Qualitative Study.
Przybyla S; LaValley S; St Vil N
J Assoc Nurses AIDS Care; 2019; 30(6):630-638. PubMed ID: 30958406
[TBL] [Abstract][Full Text] [Related]
4. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
Calabrese SK; Tekeste M; Mayer KH; Magnus M; Krakower DS; Kershaw TS; Eldahan AI; Gaston Hawkins LA; Underhill K; Hansen NB; Betancourt JR; Dovidio JF
AIDS Patient Care STDS; 2019 Feb; 33(2):79-88. PubMed ID: 30715918
[TBL] [Abstract][Full Text] [Related]
5. Pre-Exposure Prophylaxis (PrEP) for Safer Conception Among Serodifferent Couples: Findings from Healthcare Providers Serving Patients with HIV in Seven US Cities.
Finocchario-Kessler S; Champassak S; Hoyt MJ; Short W; Chakraborty R; Weber S; Levison J; Phillips J; Storm D; Anderson J
AIDS Patient Care STDS; 2016 Mar; 30(3):125-33. PubMed ID: 26824425
[TBL] [Abstract][Full Text] [Related]
6. Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada.
Grace D; Gaspar M; Wells A; Sinno J; Daroya E; Montess M; Hull M; Lachowsky NJ; Tan DHS
AIDS Patient Care STDS; 2023 Jun; 37(6):306-315. PubMed ID: 37195728
[TBL] [Abstract][Full Text] [Related]
7. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
Kenison TC; Badenhop B; Safo S
AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
[TBL] [Abstract][Full Text] [Related]
8. Interest in Long-Acting Injectable Pre-exposure Prophylaxis (LAI PrEP) Among Women in the Women's Interagency HIV Study (WIHS): A Qualitative Study Across Six Cities in the United States.
Philbin MM; Parish C; Kinnard EN; Reed SE; Kerrigan D; Alcaide ML; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Metsch LR
AIDS Behav; 2021 Mar; 25(3):667-678. PubMed ID: 32910351
[TBL] [Abstract][Full Text] [Related]
9. "Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation.
Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Hawkins LAG; Underhill K; Hansen NB; Kershaw TS; Betancourt JR; Dovidio JF
AIDS Patient Care STDS; 2017 Apr; 31(4):196-204. PubMed ID: 28414261
[TBL] [Abstract][Full Text] [Related]
10. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.
Krakower D; Ware N; Mitty JA; Maloney K; Mayer KH
AIDS Behav; 2014 Sep; 18(9):1712-21. PubMed ID: 24965676
[TBL] [Abstract][Full Text] [Related]
11. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
[TBL] [Abstract][Full Text] [Related]
12. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
Marshall BDL; Goedel WC; King MRF; Singleton A; Durham DP; Chan PA; Townsend JP; Galvani AP
Lancet HIV; 2018 Sep; 5(9):e498-e505. PubMed ID: 29908917
[TBL] [Abstract][Full Text] [Related]
13. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
Cholo FA; Dada S; Martin CE; Mullick S
J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
[TBL] [Abstract][Full Text] [Related]
14. Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.
Mullins TL; Zimet G; Lally M; Kahn JA
AIDS Patient Care STDS; 2016 Jul; 30(7):339-48. PubMed ID: 27410497
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
Bardon AR; Simoni JM; Layman LM; Stekler JD; Drain PK
AIDS Res Ther; 2020 Aug; 17(1):50. PubMed ID: 32762713
[TBL] [Abstract][Full Text] [Related]
16. Provider-Patient Communication on Pre-Exposure Prophylaxis (Prep) for HIV Prevention: An Exploration of Healthcare Provider Challenges.
Wilson K; Bleasdale J; Przybyla SM
Health Commun; 2021 Nov; 36(13):1677-1686. PubMed ID: 32633137
[TBL] [Abstract][Full Text] [Related]
17. HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.
Zhang C; McMahon J; Fiscella K; Przybyla S; Braksmajer A; LeBlanc N; Liu Y
AIDS Patient Care STDS; 2019 Dec; 33(12):507-527. PubMed ID: 31821044
[TBL] [Abstract][Full Text] [Related]
18. A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use.
Philbin MM; Parish C; Bergen S; Kerrigan D; Kinnard EN; Reed SE; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Alcaide ML; Metsch LR
AIDS Patient Care STDS; 2021 Jan; 35(1):23-30. PubMed ID: 33400587
[TBL] [Abstract][Full Text] [Related]
19. Experiences and challenges of pre-exposure prophylaxis initiation and retention among high-risk populations: qualitative insights among service providers in Thailand.
Rayanakorn A; Chautrakarn S; Intawong K; Chariyalertsak C; Khemngern P; Olson D; Chariyalertsak S
Front Public Health; 2024; 12():1366754. PubMed ID: 38813431
[TBL] [Abstract][Full Text] [Related]
20. PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia.
Xavier Hall CD; Smith JC; Driggers RA; Stoller B; Khan Z; Li J; Ignatius EH; Siegler AJ
AIDS Care; 2021 Jun; 33(6):706-711. PubMed ID: 32838546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
